BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29769518)

  • 1. A cell-penetrating artificial metalloenzyme regulates a gene switch in a designer mammalian cell.
    Okamoto Y; Kojima R; Schwizer F; Bartolami E; Heinisch T; Matile S; Fussenegger M; Ward TR
    Nat Commun; 2018 May; 9(1):1943. PubMed ID: 29769518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial metalloenzymes based on the biotin-avidin technology: enantioselective catalysis and beyond.
    Ward TR
    Acc Chem Res; 2011 Jan; 44(1):47-57. PubMed ID: 20949947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Enzymatic Cascades and Directed Evolution.
    Liang AD; Serrano-Plana J; Peterson RL; Ward TR
    Acc Chem Res; 2019 Mar; 52(3):585-595. PubMed ID: 30735358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Unnatural Catalysis Enabled by an Artificial Metalloenzyme.
    Okamoto Y; Kojima R
    Methods Mol Biol; 2021; 2312():287-300. PubMed ID: 34228297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Challenges and Opportunities.
    Heinisch T; Ward TR
    Acc Chem Res; 2016 Sep; 49(9):1711-21. PubMed ID: 27529561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexibility of a biotinylated ligand in artificial metalloenzymes based on streptavidin--an insight from molecular dynamics simulations with classical and ab initio force fields.
    Panek JJ; Ward TR; Jezierska-Mazzarello A; Novic M
    J Comput Aided Mol Des; 2010 Sep; 24(9):719-32. PubMed ID: 20526651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial metalloenzymes for olefin metathesis based on the biotin-(strept)avidin technology.
    Lo C; Ringenberg MR; Gnandt D; Wilson Y; Ward TR
    Chem Commun (Camb); 2011 Nov; 47(44):12065-7. PubMed ID: 21959544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Library design and screening protocol for artificial metalloenzymes based on the biotin-streptavidin technology.
    Mallin H; Hestericová M; Reuter R; Ward TR
    Nat Protoc; 2016 May; 11(5):835-52. PubMed ID: 27031496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking Symmetry: Engineering Single-Chain Dimeric Streptavidin as Host for Artificial Metalloenzymes.
    Wu S; Zhou Y; Rebelein JG; Kuhn M; Mallin H; Zhao J; Igareta NV; Ward TR
    J Am Chem Soc; 2019 Oct; 141(40):15869-15878. PubMed ID: 31509711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial metalloenzymes based on biotin-avidin technology for the enantioselective reduction of ketones by transfer hydrogenation.
    Letondor C; Humbert N; Ward TR
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4683-7. PubMed ID: 15772162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial metalloenzymes for enantioselective catalysis based on biotin-avidin.
    Collot J; Gradinaru J; Humbert N; Skander M; Zocchi A; Ward TR
    J Am Chem Soc; 2003 Jul; 125(30):9030-1. PubMed ID: 15369356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual anchoring strategy for the localization and activation of artificial metalloenzymes based on the biotin-streptavidin technology.
    Zimbron JM; Heinisch T; Schmid M; Hamels D; Nogueira ES; Schirmer T; Ward TR
    J Am Chem Soc; 2013 Apr; 135(14):5384-8. PubMed ID: 23496309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective Hydroxylation of Benzylic C(sp
    Serrano-Plana J; Rumo C; Rebelein JG; Peterson RL; Barnet M; Ward TR
    J Am Chem Soc; 2020 Jun; 142(24):10617-10623. PubMed ID: 32450689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical optimization of artificial metalloenzymes based on the biotin-avidin technology: (S)-selective and solvent-tolerant hydrogenation catalysts via the introduction of chiral amino acid spacers.
    Skander M; Malan C; Ivanova A; Ward TR
    Chem Commun (Camb); 2005 Oct; (38):4815-7. PubMed ID: 16193124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial metalloenzymes for enantioselective catalysis based on the noncovalent incorporation of organometallic moieties in a host protein.
    Ward TR
    Chemistry; 2005 Jun; 11(13):3798-804. PubMed ID: 15761912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designed evolution of artificial metalloenzymes: protein catalysts made to order.
    Creus M; Ward TR
    Org Biomol Chem; 2007 Jun; 5(12):1835-44. PubMed ID: 17551630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed Evolution of an Artificial Imine Reductase.
    Hestericová M; Heinisch T; Alonso-Cotchico L; Maréchal JD; Vidossich P; Ward TR
    Angew Chem Int Ed Engl; 2018 Feb; 57(7):1863-1868. PubMed ID: 29265726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-driven electron injection from a biotinylated triarylamine donor to [Ru(diimine)3](2+)-labeled streptavidin.
    Keller SG; Pannwitz A; Schwizer F; Klehr J; Wenger OS; Ward TR
    Org Biomol Chem; 2016 Jul; 14(30):7197-201. PubMed ID: 27411288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction.
    Wu SC; Ng KK; Wong SL
    Proteins; 2009 Nov; 77(2):404-12. PubMed ID: 19425108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptavidin reduces oxygen quenching of biotinylated ruthenium(II) and palladium(II) complexes.
    Soller T; Ringler M; Wunderlich M; Klar TA; Feldmann J; Josel HP; Koci J; Markert Y; Nichtl A; Kürzinger K
    J Phys Chem B; 2008 Oct; 112(40):12824-6. PubMed ID: 18783263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.